All the news

People with a genetic profile that strongly predicts non-alcoholic or metabolic-associated fatty liver disease were not at higher risk of being hospitalised with COVID-19 in the United Kingdom, an analysis of the ...

People with chronic liver disease admitted to hospital with COVID-19 are dying at a much higher rate than the rest of the population, figures collated by liver specialists in Europe, Asia and ...

A quarter of people living with HIV with normal body weight have non-alcoholic-fatty liver disease (NAFLD), Italian and Canadian investigators report in Clinical Infectious Diseases. Risk factors were older age, ...

An eight-week course of grazoprevir/elbasvir (Zepatier) achieved a high cure rate in people recently infected with hepatitis C, but another study found that a six-week course of sofosbuvir/velpatasvir (Epclusa) resulted in an inferior ...

Treatment for hepatitis C was highly effective in clearing the virus in young people co-infected with HIV and hepatitis C through vertical infection, despite advanced fibrosis in one-third, Spanish researchers report in the ...

Liver specialists in New York report a high frequency of severe COVID-19 cases in organ transplant recipients who became infected with SARS-CoV-2, while Italian specialists report that 15 of 17 patients who underwent ...

A preliminary analysis of people admitted to hospital in China with COVID-19 symptoms shows that people with non-alcoholic fatty liver disease (NAFLD) were six times more likely to progress to severe COVID-19 ...

Hepatitis C is spreading rapidly among HIV-positive men who have sex with men (MSM) in Bangkok and is associated with use of crystal methamphetamine, research presented to the recent Conference ...

Directly observed treatment for hepatitis C achieved a very high cure rate in people who inject drugs, an Austrian study carried out in pharmacies and drugs projects offering opioid substitution therapy has reported. The ...